A systematic review and meta-analysis with focus on radiotherapy of pediatric standard-risk medulloblastoma : New strategies are needed to improve survival and reduce side-effects
We explored the impact of different radiotherapy (RT) treatment modalities and prescriptions on outcomes for standard risk pediatric medulloblastoma patients (MB-SR). A systematic review and meta-analysis were performed. Primary MB-SR patients, aged 3–21 years treated with cranio-spinal axis and tumor boost RT during 1995–2024 were included. Data on progression-free and overall survival outcomes (
